Cardinal Health (NYSE:CAH) Cut to D at TheStreet

TheStreet lowered shares of Cardinal Health (NYSE:CAH) from a c+ rating to a d rating in a research note released on Thursday morning, TheStreetRatingsTable reports.

A number of other research firms have also weighed in on CAH. Argus lowered shares of Cardinal Health from a buy rating to a hold rating in a research note on Tuesday, August 27th. Morgan Stanley cut their target price on shares of Cardinal Health from $50.00 to $41.00 and set an underweight rating on the stock in a research note on Friday, September 6th. Guggenheim set a $55.00 target price on shares of Cardinal Health and gave the stock a buy rating in a research note on Thursday, September 12th. ValuEngine upgraded shares of Cardinal Health from a strong sell rating to a sell rating in a research note on Wednesday, October 2nd. Finally, Deutsche Bank assumed coverage on shares of Cardinal Health in a research note on Thursday, September 12th. They set a hold rating and a $50.00 target price on the stock. Three research analysts have rated the stock with a sell rating, seven have assigned a hold rating and one has issued a buy rating to the stock. The company has a consensus rating of Hold and an average price target of $53.50.

NYSE:CAH traded up $0.55 on Thursday, reaching $53.75. 3,313,580 shares of the company’s stock were exchanged, compared to its average volume of 2,953,817. The company has a quick ratio of 0.54, a current ratio of 1.07 and a debt-to-equity ratio of 1.20. The firm has a market capitalization of $15.06 billion, a price-to-earnings ratio of 10.18, a price-to-earnings-growth ratio of 1.72 and a beta of 1.32. The business has a fifty day moving average of $48.75 and a 200-day moving average of $46.39. Cardinal Health has a 52-week low of $41.03 and a 52-week high of $58.31.

Cardinal Health (NYSE:CAH) last released its earnings results on Thursday, November 7th. The company reported $1.27 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.09 by $0.18. Cardinal Health had a net margin of 0.94% and a return on equity of 25.96%. The firm had revenue of $37.34 billion for the quarter, compared to analyst estimates of $36.75 billion. During the same period in the prior year, the firm earned $1.29 earnings per share. The business’s quarterly revenue was up 6.0% compared to the same quarter last year. As a group, equities analysts anticipate that Cardinal Health will post 4.99 earnings per share for the current year.

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. MML Investors Services LLC boosted its holdings in shares of Cardinal Health by 1.2% in the second quarter. MML Investors Services LLC now owns 19,478 shares of the company’s stock valued at $917,000 after acquiring an additional 225 shares during the period. Rockland Trust Co. boosted its holdings in shares of Cardinal Health by 1.4% in the second quarter. Rockland Trust Co. now owns 16,807 shares of the company’s stock valued at $792,000 after acquiring an additional 231 shares during the period. Exeter Financial LLC boosted its holdings in shares of Cardinal Health by 1.5% in the third quarter. Exeter Financial LLC now owns 15,820 shares of the company’s stock valued at $747,000 after acquiring an additional 236 shares during the period. First Allied Advisory Services Inc. boosted its holdings in shares of Cardinal Health by 2.2% in the third quarter. First Allied Advisory Services Inc. now owns 11,759 shares of the company’s stock valued at $555,000 after acquiring an additional 248 shares during the period. Finally, Securian Asset Management Inc boosted its holdings in shares of Cardinal Health by 0.9% in the second quarter. Securian Asset Management Inc now owns 30,656 shares of the company’s stock valued at $1,444,000 after acquiring an additional 265 shares during the period. 90.17% of the stock is owned by hedge funds and other institutional investors.

Cardinal Health Company Profile

Cardinal Health, Inc operates as an integrated healthcare services and products company in the United States and internationally. It provides medical products and pharmaceuticals, and solutions that enhance supply chain efficiency for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices.

Featured Story: Outstanding Shares

Analyst Recommendations for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit